Practice Point CME - Hematology Podcast: Episode 25 - Integrating Quadruplet Regimens in Newly Diagnosed Multiple Myeloma: Patient Focused Strategies to Improve Outcomes - Part 1
Description
In this podcast series, Dr. Orlowski, Dr. Raje, and Dr. Voorhees inform and guide participants on latest developments from clinical trials on quadruplet and triplet regimens, based on updates from the European Hematology Association (EHA) 2024 meeting. Using clinical case scenarios, they’ll clarify clinical endpoints and outcomes to enable safe and effective frontline regimen choices among diverse patients with newly diagnosed multiple myeloma (NDMM) who have distinct needs. Listen to the available episodes as experts lay the foundation for optimal first-line, maintenance, transplantation, and subsequent therapy choice based on the risk profile of patients, to ultimately improve outcomes in multiple myeloma (MM).
Launch Date: July 19, 2024
Release Date: June 26, 2024
Expiration Date: June 30, 2025
FACULTY
Robert Orlowski, MD, PhD
Professor of Medicine
Director, Section of Myeloma
The University of Texas, MD Anderson Cancer Center
Noopur Raje, MD
Director, Center for Multiple Myeloma
Massachusetts General Hospital
Peter Voorhees, MD
Chief, Plasma Cell Disorders Division
Atrium Health / Levine Cancer Institute
Clinical Professor of Medicine
Wake Forest University School of Medicine
This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.
Episode: https://rss.com/podcasts/practice-point-communications-hematology-podcast/1856534
Podcast: https://rss.com/podcasts/practice-point-communications-hematology-podcast
United States
